What Comes Next For Xero (XRO) After A 65% Fall

If you had backed Xero for its AI push and US expansion a year ago, the outcome has been brutal. Investors who held Xero over the past year are down 64.6%, including dividends. That loss comes even after FY26 revenue reached about NZ$2.8b and management pushed ahead with Melio, JAX and new premium tiers. So what did the original 2025 investment case miss about integration costs, margin pressure and the high P/E needed to support those growth assumptions?

Narratives are how investors here put a case on the record, with explicit assumptions about revenue, margins and the multiple. Those assumptions imply an estimated Fair Value.

This theme extends beyond Xero. See which of 91 AI infrastructure stocks may still merit a closer look.

The Argument Xero Investors Were Actually Weighing

The shares cost A$158 at the start of the period, and Xero sat between two very different but reasonable stories about what came next.

On the optimistic side, the AI and US expansion Narrative put Fair Value at A$195, 24% above the start price. It leaned on revenue growth of 18.1% and a future P/E of 61.4x as assumptions, helped by expectations that AI features and embedded bill payments would improve satisfaction and retention.

The bearish Narrative anchored on cybersecurity and regulatory strain put Fair Value at A$100, 36% below the start price. It focused on rising compliance and security spend as key risks, with the concern that higher costs and market saturation could pressure margins and slow subscriber growth.

What The Xero Results Put To The Test

The integration of Melio and the rollout of AI tools like JAX provided support for the optimistic Xero story that focused on product depth and US reach. The numbers, however, told a tougher tale. Revenue rose from NZ$1,106.8m in H2 2025 to NZ$1,558.9m in H2 2026, while net income and net margin both fell, so the higher profit and margin assumptions remained unproven. Overall, the evidence pointed in both directions.

The key assumption here was that new platforms would lift both growth and profitability. When assessing another software stock, track whether net margin rises alongside new product or market launches, rather than assuming that scale will eventually improve earnings.

What The Fall In Xero’s Share Price Now Asks You To Believe

Xero trades at A$55.71 today, and the selected bullish Narrative places its Fair Value above that level rather than below it. The story leans on strong scalability and the idea that AI tools could support faster feature development without matching expense growth.

Anyone paying today's price is effectively asking whether revenue and profit margins can strengthen together as AI pressure forces weaker software rivals to prove their P/E multiples faster than Xero.

"Xero has high scalability of its products, with current gross margin of ~88%. The higher revenue will be applied across relatively static operating expenses as Xero reaches the point where it can continue steady feature rollouts without needing to increase spending relative to revenue. This would result in higher net profit margins."

That disagreement has a full argument behind it. → Uncover the higher Fair Value this Narrative argues for

Looking Beyond Xero’s AI Story

Xero shows how hard it is to turn AI ambition into cleaner margins. You might ask where the same AI demand could meet a different kind of business model.

One large software group leans on an ecosystem instead of a single product. It folds AI into cloud infrastructure, workplace tools and developer platforms used together.

Customers use that stack to run workloads, write code and secure data. The AI push layers onto services that already sit inside daily workflows.

That mix ties new demand to existing habits rather than fresh adoption. The interesting question is how that changes the durability of its cash generation.

One Narrative has already put a figure on it. → Uncover the company trading 21% below one Narrative's Fair Value

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com